Cargando…

Tph Cells Expanded in Primary Sjögren’s Syndrome

OBJECTIVES: PD-1(+)CXCR5(–)CD4(+)T peripheral helper cells, named Tph cells, contribute to B-cell immune responses and the production of antibodies in systemic lupus erythematosus and rheumatoid arthritis. However, the role of Tph cells was unknown in the pathogenesis of primary Sjögren’s syndrome (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Weiqian, Yang, Fan, Lin, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218540/
https://www.ncbi.nlm.nih.gov/pubmed/35755031
http://dx.doi.org/10.3389/fmed.2022.900349
_version_ 1784731914437918720
author Chen, Weiqian
Yang, Fan
Lin, Jin
author_facet Chen, Weiqian
Yang, Fan
Lin, Jin
author_sort Chen, Weiqian
collection PubMed
description OBJECTIVES: PD-1(+)CXCR5(–)CD4(+)T peripheral helper cells, named Tph cells, contribute to B-cell immune responses and the production of antibodies in systemic lupus erythematosus and rheumatoid arthritis. However, the role of Tph cells was unknown in the pathogenesis of primary Sjögren’s syndrome (pSS). Here, we aim to explore the contribution of Tph cells in the development of pSS. METHODS: Sixty patients with pSS and 61 age and sex-matched healthy individuals were recruited for this study. The frequency of Tph cells in the blood was measured by flow cytometry. The expression of inducible T-cell costimulator (ICOS), MHC-II, IL-21, CCR2, CCR5, and CCR9 was evaluated in Tph cells. The relationship between Tph cells and indicators of clinical disease was assessed. Co-expression levels of PD-1, CXCR5, CD4, CCR2, and CCR5 in the salivary gland specimens from patients with pSS and patients with dry mouth and eyes but normal pathology were also analyzed. RESULTS: We demonstrated increased circulating Tph cells (7.53 ± 6.65% vs. 3.08 ± 1.31%, p < 0.0001) in patients with pSS (n = 60) compared to healthy controls (n = 61). Tph cells were significantly associated with the ESSDAI disease activity scores, IgG, ESR, IL-21, anti-SSA antibody, and CD138(+)/CD19(+) plasma cells. Furthermore, ICOS was highly expressed in Tfh and Tph cells in patients with pSS. IL-21, MHC-II, CCR2, and CCR5 expression was higher in pSS Tph cells, and CCR9 expression was lower in pSS Tph cells than in pSS Tfh cells. Moreover, Tph cells and CCR2(+)CD4(+)T and CCR5(+)CD4(+)T cells were found in the labial gland of patients with pSS. CONCLUSION: Our data show that Tph cells were enriched in peripheral blood and labial gland of patients with pSS. Circulating Tph cells correlated with disease activity scores, suggesting a crucial role of Tph in the development of pSS.
format Online
Article
Text
id pubmed-9218540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92185402022-06-24 Tph Cells Expanded in Primary Sjögren’s Syndrome Chen, Weiqian Yang, Fan Lin, Jin Front Med (Lausanne) Medicine OBJECTIVES: PD-1(+)CXCR5(–)CD4(+)T peripheral helper cells, named Tph cells, contribute to B-cell immune responses and the production of antibodies in systemic lupus erythematosus and rheumatoid arthritis. However, the role of Tph cells was unknown in the pathogenesis of primary Sjögren’s syndrome (pSS). Here, we aim to explore the contribution of Tph cells in the development of pSS. METHODS: Sixty patients with pSS and 61 age and sex-matched healthy individuals were recruited for this study. The frequency of Tph cells in the blood was measured by flow cytometry. The expression of inducible T-cell costimulator (ICOS), MHC-II, IL-21, CCR2, CCR5, and CCR9 was evaluated in Tph cells. The relationship between Tph cells and indicators of clinical disease was assessed. Co-expression levels of PD-1, CXCR5, CD4, CCR2, and CCR5 in the salivary gland specimens from patients with pSS and patients with dry mouth and eyes but normal pathology were also analyzed. RESULTS: We demonstrated increased circulating Tph cells (7.53 ± 6.65% vs. 3.08 ± 1.31%, p < 0.0001) in patients with pSS (n = 60) compared to healthy controls (n = 61). Tph cells were significantly associated with the ESSDAI disease activity scores, IgG, ESR, IL-21, anti-SSA antibody, and CD138(+)/CD19(+) plasma cells. Furthermore, ICOS was highly expressed in Tfh and Tph cells in patients with pSS. IL-21, MHC-II, CCR2, and CCR5 expression was higher in pSS Tph cells, and CCR9 expression was lower in pSS Tph cells than in pSS Tfh cells. Moreover, Tph cells and CCR2(+)CD4(+)T and CCR5(+)CD4(+)T cells were found in the labial gland of patients with pSS. CONCLUSION: Our data show that Tph cells were enriched in peripheral blood and labial gland of patients with pSS. Circulating Tph cells correlated with disease activity scores, suggesting a crucial role of Tph in the development of pSS. Frontiers Media S.A. 2022-06-09 /pmc/articles/PMC9218540/ /pubmed/35755031 http://dx.doi.org/10.3389/fmed.2022.900349 Text en Copyright © 2022 Chen, Yang and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Weiqian
Yang, Fan
Lin, Jin
Tph Cells Expanded in Primary Sjögren’s Syndrome
title Tph Cells Expanded in Primary Sjögren’s Syndrome
title_full Tph Cells Expanded in Primary Sjögren’s Syndrome
title_fullStr Tph Cells Expanded in Primary Sjögren’s Syndrome
title_full_unstemmed Tph Cells Expanded in Primary Sjögren’s Syndrome
title_short Tph Cells Expanded in Primary Sjögren’s Syndrome
title_sort tph cells expanded in primary sjögren’s syndrome
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218540/
https://www.ncbi.nlm.nih.gov/pubmed/35755031
http://dx.doi.org/10.3389/fmed.2022.900349
work_keys_str_mv AT chenweiqian tphcellsexpandedinprimarysjogrenssyndrome
AT yangfan tphcellsexpandedinprimarysjogrenssyndrome
AT linjin tphcellsexpandedinprimarysjogrenssyndrome